已受理，完成質(zhì)量復(fù)核，轉(zhuǎn)CDE。已在歐洲、美國登記注冊。索利那新用于改善膀胱過度活動癥引發(fā)的尿頻、尿急和尿失禁等癥狀。本品對膀胱M3受體有高新和力，能選擇性抑制膀胱節(jié)律性收縮而不影響唾液分泌，吸收不受食物影響，主要經(jīng)CY3A4代謝，老年患者無需調(diào)整劑量。與達非那新相比較，其對膀胱膽堿M3受體的選擇性更專一，對受體抑制活性更強，用藥安全性和耐受性較好，對中樞神經(jīng)、人體認知功能的影響及心血管危險性較低。
安森博有近二十年進口藥品注冊經(jīng)驗，80多個進口藥品成功注冊案例。
業(yè)務(wù)范圍：1、進口藥品代理；2、進口藥品注冊委托服務(wù)；3、尋找進口制劑國內(nèi)銷售合作伙伴。
如您對我們的進口原料藥感興趣，只需采購即可，我們負責(zé)進口原料藥注冊等。目前我公司已有近30個進口原料藥在CDE排隊待審，50多個進口原料藥的資料在整理中。已有60多家國內(nèi)制劑廠采購我們的原料藥。
我們代理的進口制劑，已經(jīng)在歐美已經(jīng)或即將上市銷售，質(zhì)量可靠，期待與您合作。
We are a trade company. We are very strong in registration and promotion of import drugs in China, with decades of registration experience and over 86 Licenses procured successfully.
We submitted about 10 import drug applications per year since 2011;
Our knowledge, experience and good working relationship with the regulatory department help us to speed up regulatory approvals and to provide sound support for our formulation customers.
We procured 5 new IDLs in 2010, among which one license was obtained within 10 months and another was obtained within 12 months.
We do not manufacture API and formulation, only focus on registration and promotion of import drug in China.
進口原料藥代理、注冊，承接進口藥品注冊委托服務(wù)
琥珀酸索利那新（Solifenacin） 產(chǎn)品信息
在找 琥珀酸索利那新（Solifenacin） 產(chǎn)品的人還在看
采購中心
